Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.
about
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patientsMyeloid toxicity of cancer treatment.Febrile neutropenia in hematologic malignancies.Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer.Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial.Clinical and economic burden of emergency department presentations for neutropenia following outpatient chemotherapy for cancer in Victoria, Australia.Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia.Antimicrobial stewardship in patients with cancer.The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.Admission avoidance hospital at home.Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.
P2860
Q24197538-8658AA17-0E2C-4E3E-9F98-7AFE3946F965Q33416472-FC6357C4-B979-410F-96D9-54DF45FAAF36Q34655730-BC1F6E90-5506-4D19-A2BC-3928DB6D8F03Q34670717-F5EA170A-C4BC-46F6-AE98-19493A9C7387Q35078855-8C8F90CB-3D48-445F-BB87-423B08D1D4A6Q35532487-567CD1AF-1EA0-4C1D-87A5-E9E0C157AA22Q36102853-193198C9-D0F0-4568-9F4C-E06B8C5C2752Q38068457-37B48917-3354-4709-951D-08674C0E1925Q38073198-DF57EA43-86F9-42A5-8957-7592F4C9BCA3Q38084890-2F3FE7CE-8B4C-441B-B65F-13011E0C19FFQ38115356-61567BB8-6480-4A9B-90D0-53AE3E52F62DQ38909993-5E3C3472-CD58-4267-951D-0890EDD32971Q38943588-86618288-A97F-498B-97E0-DFDEF65A69F0Q40242261-800B4BAE-A4EB-44CD-BC3A-E2D3245207C1Q47425293-B83F7BE9-CB29-42DF-81DE-5E42FE707B81
P2860
Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Safety of early discharge for ...... r randomized controlled trial.
@en
type
label
Safety of early discharge for ...... r randomized controlled trial.
@en
prefLabel
Safety of early discharge for ...... r randomized controlled trial.
@en
P2093
P2860
P356
P1476
Safety of early discharge for ...... er randomized controlled trial
@en
P2093
Beow Y Yeap
Charles Lu
Elizabeth Trice Loggers
James A Talcott
Paul A Godley
Robert D Siegel
P2860
P304
P356
10.1200/JCO.2011.35.0884
P407
P50
P577
2011-09-19T00:00:00Z